First of all, if I didn't care, I would not have spent $2 million in developing these products to be shipped to those countries where people are dying. We did it because as a Canadian company it was the right thing to do.
I do agree with you that, as one of the other members stated, maybe the right way to handle this is for CIDA to be buying products, whether it be from a Canadian generic company, whether it be from my friends from the brand industry, or whether it's even from companies manufacturing generics in India, in order that Canadians do the right thing in helping to save lives.